Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:07 pm
| PEG Ratio | 1.13 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Alembic Ltd operates within the realty sector and has reported a notable recovery in its financial performance. For the fiscal year ending March 2025, the company recorded sales of ₹222 Cr, an increase from ₹157 Cr in March 2024 and a substantial rise from ₹127 Cr in March 2023. Quarterly sales data indicates consistent growth, with the latest reported quarter (June 2025) achieving sales of ₹60 Cr. This upward trajectory reflects a strategic focus on enhancing operational capabilities and tapping into market demand. The company’s operating profit margin (OPM) stood at 42% for FY 2025, indicating strong profitability relative to revenue. Additionally, Alembic’s trailing twelve-month (TTM) sales reflect this growth trend, with TTM sales reported at ₹221 Cr. The company’s ability to adapt to market fluctuations and optimize its operations has been essential in achieving these results, positioning it favorably against sector norms that often see lower growth rates in similar contexts.
Profitability and Efficiency Metrics
Alembic Ltd’s profitability metrics reveal a robust operational framework, with a reported net profit of ₹311 Cr for FY 2025, up from ₹269 Cr in FY 2024. The company’s return on equity (ROE) was recorded at 13.7%, which is competitive compared to typical industry standards. The interest coverage ratio (ICR) of 68.23x indicates that Alembic can comfortably meet its interest obligations, reflecting financial prudence. The operating profit also showed resilience with an OPM of 42%, which is significantly higher than the average OPM in the realty sector, typically ranging between 20-30%. The cash conversion cycle (CCC) stood at 49 days, indicating efficient management of working capital. However, the return on capital employed (ROCE) was lower at 6.90%, suggesting that while the company is profitable, there is room for improvement in capital efficiency. Overall, Alembic’s strong profitability metrics position it well against competitors in the real estate market.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alembic Ltd exhibits considerable strength, with total assets amounting to ₹2,503 Cr as of March 2025. The company has maintained minimal borrowings, reported at ₹14 Cr, resulting in a debt-to-equity ratio of 0.01, which is exceptionally low and indicates a conservative approach to financing. Reserves have increased to ₹2,287 Cr, enhancing the company’s financial cushion for future investments and contingencies. The book value per share stood at ₹91.07, reflecting solid equity backing for shareholders. Furthermore, the current ratio of 1.85 suggests that Alembic has adequate liquidity to cover its short-term liabilities, which is favorable compared to the industry average. However, the low inventory turnover ratio at 0.08 could indicate inefficiencies in inventory management, which may require strategic attention. Overall, the balance sheet reflects a well-capitalized entity with strong financial ratios that support growth initiatives.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alembic Ltd shows a dominant promoter holding of 70.88%, indicating strong control and commitment from the founding family. This stable ownership structure can foster investor confidence, particularly among institutional investors. Foreign institutional investors (FIIs) have gradually increased their stake from 0.70% in March 2023 to 1.65% by March 2025, suggesting a growing interest in the company from overseas investors. Conversely, domestic institutional investors (DIIs) have seen a decline in their holdings, standing at just 0.05% as of March 2025, which may raise concerns about local institutional interest. The public shareholding has seen a slight increase to 27.57%, reflecting a steady participation from retail investors. The total number of shareholders has also risen to 1,07,510, indicating a growing base of retail participation. Overall, the shareholding dynamics reflect a solid foundation but highlight the need for strategies to engage domestic institutional investors more effectively.
Outlook, Risks, and Final Insight
The outlook for Alembic Ltd appears promising, supported by its strong revenue growth and financial metrics. However, the company faces several risks, including potential market volatility in the realty sector and the ongoing challenge of managing inventory efficiently, as indicated by its low turnover ratio. Additionally, the reliance on promoter holdings may pose governance risks if not managed transparently. The increasing interest from FIIs can be a double-edged sword; while it enhances liquidity, it may also subject the company to fluctuations in foreign investment sentiment. To mitigate these risks, Alembic could focus on improving operational efficiencies and engaging more actively with domestic institutional investors. In scenarios of continued growth, the company could leverage its strong balance sheet to explore expansion opportunities, while a downturn in market conditions could necessitate a reevaluation of its operational strategies. Overall, Alembic Ltd’s financial health and growth potential make it a noteworthy player in the realty sector, but vigilance is required to navigate potential challenges.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alembic Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hampton Sky Realty Ltd | 500 Cr. | 18.2 | 35.8/18.0 | 5.32 | 0.00 % | 6.07 % | 3.84 % | 1.00 | |
| Grovy India Ltd | 50.8 Cr. | 38.1 | 87.1/37.0 | 16.2 | 15.3 | 0.26 % | 7.63 % | 9.12 % | 10.0 |
| Gothi Plascon (India) Ltd | 40.8 Cr. | 40.0 | 53.6/36.3 | 26.9 | 11.0 | 4.99 % | 18.8 % | 14.2 % | 10.0 |
| Generic Engineering Construction & Projects Ltd | 236 Cr. | 41.4 | 55.9/22.0 | 19.4 | 49.9 | 0.00 % | 7.55 % | 2.97 % | 5.00 |
| Garnet Construction Ltd | 93.8 Cr. | 67.4 | 76.0/21.6 | 5.10 | 74.0 | 0.00 % | 9.96 % | 7.47 % | 10.0 |
| Industry Average | 20,034.60 Cr | 482.19 | 76.99 | 146.17 | 0.55% | 12.99% | 12.86% | 6.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 37 | 31 | 37 | 37 | 32 | 39 | 49 | 51 | 53 | 58 | 60 | 50 |
| Expenses | 17 | 26 | 20 | 24 | 26 | 22 | 28 | 25 | 30 | 33 | 32 | 33 | 30 |
| Operating Profit | 5 | 11 | 10 | 13 | 11 | 10 | 12 | 24 | 20 | 20 | 26 | 27 | 20 |
| OPM % | 25% | 30% | 34% | 36% | 30% | 31% | 30% | 49% | 40% | 37% | 46% | 45% | 39% |
| Other Income | 1 | 59 | 2 | -9 | 3 | 48 | 2 | 2 | 2 | 66 | 4 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 1 | 2 | 3 | 3 | 3 | 3 |
| Profit before tax | 4 | 68 | 11 | 3 | 12 | 56 | 11 | 24 | 19 | 82 | 27 | 27 | 20 |
| Tax % | 11% | 10% | 2% | -55% | 14% | 8% | 9% | 12% | 10% | 6% | 5% | 12% | 10% |
| Net Profit | -19 | 115 | 46 | 48 | 44 | 91 | 61 | 72 | 56 | 121 | 65 | 68 | 62 |
| EPS in Rs | -0.72 | 4.49 | 1.78 | 1.88 | 1.73 | 3.53 | 2.39 | 2.81 | 2.17 | 4.71 | 2.55 | 2.67 | 2.40 |
Last Updated: August 20, 2025, 2:05 pm
Below is a detailed analysis of the quarterly data for Alembic Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 50.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 50.00 Cr., marking a decrease of 10.00 Cr..
- For Expenses, as of Jun 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 39.00%. The value appears to be declining and may need further review. It has decreased from 45.00% (Mar 2025) to 39.00%, marking a decrease of 6.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For Tax %, as of Jun 2025, the value is 10.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Mar 2025) to 10.00%, marking a decrease of 2.00%.
- For Net Profit, as of Jun 2025, the value is 62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 62.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.40. The value appears to be declining and may need further review. It has decreased from 2.67 (Mar 2025) to 2.40, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:20 pm
| Metric | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,121 | 144 | 134 | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 157 | 222 | 221 |
| Expenses | 1,018 | 134 | 128 | 140 | 114 | 106 | 71 | 62 | 64 | 87 | 101 | 128 | 128 |
| Operating Profit | 103 | 10 | 6 | 7 | 11 | 18 | 3 | 11 | 14 | 40 | 57 | 94 | 93 |
| OPM % | 9% | 7% | 5% | 5% | 9% | 15% | 4% | 15% | 18% | 32% | 36% | 42% | 42% |
| Other Income | 16 | 21 | 25 | 25 | 37 | 29 | 93 | 10 | 89 | 54 | 55 | 75 | 77 |
| Interest | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
| Depreciation | 43 | 6 | 6 | 5 | 4 | 3 | 3 | 4 | 5 | 7 | 8 | 11 | 11 |
| Profit before tax | 44 | 23 | 25 | 27 | 44 | 45 | 93 | 17 | 98 | 87 | 103 | 156 | 156 |
| Tax % | 10% | -3% | 2% | -3% | 5% | 8% | 0% | 19% | 12% | 7% | 10% | 7% | |
| Net Profit | 40 | 107 | 235 | 145 | 163 | 213 | 329 | 343 | 222 | 191 | 269 | 311 | 316 |
| EPS in Rs | 1.48 | 3.99 | 8.78 | 5.45 | 6.10 | 8.30 | 12.82 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 | 12.33 |
| Dividend Payout % | 17% | 4% | 2% | 4% | 3% | 2% | 5% | 2% | 21% | 30% | 23% | 20% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 119.63% | -38.30% | 12.41% | 30.67% | 54.46% | 4.26% | -35.28% | -13.96% | 40.84% | 15.61% |
| Change in YoY Net Profit Growth (%) | 0.00% | -157.92% | 50.71% | 18.26% | 23.79% | -50.20% | -39.53% | 21.31% | 54.80% | -25.22% |
Alembic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 25% |
| 3 Years: | 42% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -1% |
| 3 Years: | 12% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 2% |
| 3 Years: | 13% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 14% |
Last Updated: September 4, 2025, 10:45 pm
Balance Sheet
Last Updated: October 10, 2025, 1:35 pm
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 53 | 53 | 53 | 53 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| Reserves | 311 | 474 | 750 | 858 | 1,032 | 1,157 | 1,367 | 2,246 | 2,445 | 2,027 | 2,134 | 2,287 |
| Borrowings | 408 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 14 |
| Other Liabilities | 251 | 91 | 64 | 81 | 73 | 57 | 53 | 112 | 135 | 127 | 134 | 150 |
| Total Liabilities | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 |
| Fixed Assets | 393 | 169 | 146 | 171 | 179 | 209 | 225 | 265 | 297 | 321 | 369 | 409 |
| CWIP | 4 | 2 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 1 | 0 |
| Investments | 8 | 299 | 605 | 732 | 913 | 1,001 | 1,133 | 2,047 | 2,208 | 1,754 | 1,786 | 1,900 |
| Other Assets | 591 | 149 | 124 | 89 | 67 | 55 | 110 | 91 | 127 | 130 | 173 | 194 |
| Total Assets | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 |
Below is a detailed analysis of the balance sheet data for Alembic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 51.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 51.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,287.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,134.00 Cr. (Mar 2024) to 2,287.00 Cr., marking an increase of 153.00 Cr..
- For Borrowings, as of Mar 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 134.00 Cr. (Mar 2024) to 150.00 Cr., marking an increase of 16.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,503.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,329.00 Cr. (Mar 2024) to 2,503.00 Cr., marking an increase of 174.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 409.00 Cr.. The value appears strong and on an upward trend. It has increased from 369.00 Cr. (Mar 2024) to 409.00 Cr., marking an increase of 40.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 1,900.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,786.00 Cr. (Mar 2024) to 1,900.00 Cr., marking an increase of 114.00 Cr..
- For Other Assets, as of Mar 2025, the value is 194.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 194.00 Cr., marking an increase of 21.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,503.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,329.00 Cr. (Mar 2024) to 2,503.00 Cr., marking an increase of 174.00 Cr..
Notably, the Reserves (2,287.00 Cr.) exceed the Borrowings (14.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -305.00 | 10.00 | -3.00 | 7.00 | 11.00 | 18.00 | 3.00 | 11.00 | 14.00 | 40.00 | 48.00 | 80.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 122 | 76 | 54 | 74 | 40 | 44 | 69 | 71 | 67 | 46 | 49 |
| Inventory Days | 158 | 880 | 659 | 438 | 247 | 289 | 411 | 2,112 | 2,885 | 3,694 | ||
| Days Payable | 128 | 200 | 144 | 128 | 125 | 202 | 151 | 693 | 640 | 1,237 | ||
| Cash Conversion Cycle | 93 | 801 | 591 | 364 | 195 | 126 | 305 | 1,488 | 2,316 | 67 | 2,502 | 49 |
| Working Capital Days | 108 | 235 | 172 | 39 | 20 | 13 | 22 | 97 | 223 | 118 | 77 | 57 |
| ROCE % | 10% | 4% | 4% | 4% | 4% | 7% | 1% | 4% | 4% | 5% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 10,000,000 | 0.39 | 81.35 | 10,000,000 | 2025-04-22 14:12:25 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| Diluted EPS (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| Cash EPS (Rs.) | 6.04 | 3.92 | 3.40 | 3.55 | 0.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.07 | 85.11 | 80.93 | 97.23 | 89.45 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.07 | 85.11 | 80.93 | 97.23 | 89.45 |
| Revenue From Operations / Share (Rs.) | 8.64 | 6.13 | 4.96 | 3.05 | 2.86 |
| PBDIT / Share (Rs.) | 6.57 | 4.35 | 4.07 | 4.02 | 0.83 |
| PBIT / Share (Rs.) | 6.15 | 4.04 | 3.81 | 3.83 | 0.67 |
| PBT / Share (Rs.) | 6.06 | 4.00 | 3.38 | 3.81 | 0.66 |
| Net Profit / Share (Rs.) | 5.63 | 3.62 | 3.14 | 3.36 | 0.53 |
| NP After MI And SOA / Share (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| PBDIT Margin (%) | 75.98 | 70.88 | 82.20 | 131.82 | 29.03 |
| PBIT Margin (%) | 71.19 | 65.90 | 76.91 | 125.60 | 23.67 |
| PBT Margin (%) | 70.08 | 65.20 | 68.21 | 125.10 | 23.18 |
| Net Profit Margin (%) | 65.15 | 58.96 | 63.35 | 110.19 | 18.82 |
| NP After MI And SOA Margin (%) | 140.01 | 170.56 | 149.83 | 283.89 | 466.35 |
| Return on Networth / Equity (%) | 13.28 | 12.29 | 9.17 | 8.89 | 14.92 |
| Return on Capital Employeed (%) | 6.60 | 4.63 | 4.61 | 3.83 | 0.74 |
| Return On Assets (%) | 12.41 | 11.53 | 8.64 | 8.43 | 14.23 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.09 | 0.06 | 0.05 | 0.04 | 0.06 |
| Current Ratio (X) | 1.85 | 1.52 | 2.05 | 2.12 | 1.72 |
| Quick Ratio (X) | 0.95 | 0.49 | 0.99 | 0.83 | 0.80 |
| Inventory Turnover Ratio (X) | 0.08 | 0.09 | 0.07 | 0.12 | 0.26 |
| Dividend Payout Ratio (NP) (%) | 19.83 | 21.03 | 24.24 | 2.31 | 4.49 |
| Dividend Payout Ratio (CP) (%) | 19.18 | 20.43 | 23.41 | 2.26 | 4.44 |
| Earning Retention Ratio (%) | 80.17 | 78.97 | 75.76 | 97.69 | 95.51 |
| Cash Earning Retention Ratio (%) | 80.82 | 79.57 | 76.59 | 97.74 | 95.56 |
| Interest Coverage Ratio (X) | 68.23 | 100.70 | 224.79 | 265.00 | 58.96 |
| Interest Coverage Ratio (Post Tax) (X) | 59.51 | 84.77 | 197.06 | 222.52 | 39.24 |
| Enterprise Value (Cr.) | 2539.12 | 2154.92 | 1520.56 | 1855.97 | 2634.71 |
| EV / Net Operating Revenue (X) | 11.44 | 13.68 | 11.95 | 23.73 | 35.84 |
| EV / EBITDA (X) | 15.06 | 19.30 | 14.54 | 18.00 | 123.44 |
| MarketCap / Net Operating Revenue (X) | 11.40 | 13.64 | 11.97 | 23.75 | 35.92 |
| Retention Ratios (%) | 80.16 | 78.96 | 75.75 | 97.68 | 95.50 |
| Price / BV (X) | 1.08 | 0.98 | 0.73 | 0.74 | 1.15 |
| Price / Net Operating Revenue (X) | 11.40 | 13.64 | 11.97 | 23.75 | 35.93 |
| EarningsYield | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
After reviewing the key financial ratios for Alembic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.04. This value is within the healthy range. It has increased from 3.92 (Mar 24) to 6.04, marking an increase of 2.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.07. It has increased from 85.11 (Mar 24) to 91.07, marking an increase of 5.96.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.07. It has increased from 85.11 (Mar 24) to 91.07, marking an increase of 5.96.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 8.64. It has increased from 6.13 (Mar 24) to 8.64, marking an increase of 2.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.57. This value is within the healthy range. It has increased from 4.35 (Mar 24) to 6.57, marking an increase of 2.22.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 4.04 (Mar 24) to 6.15, marking an increase of 2.11.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.06. This value is within the healthy range. It has increased from 4.00 (Mar 24) to 6.06, marking an increase of 2.06.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 3.62 (Mar 24) to 5.63, marking an increase of 2.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For PBDIT Margin (%), as of Mar 25, the value is 75.98. This value is within the healthy range. It has increased from 70.88 (Mar 24) to 75.98, marking an increase of 5.10.
- For PBIT Margin (%), as of Mar 25, the value is 71.19. This value exceeds the healthy maximum of 20. It has increased from 65.90 (Mar 24) to 71.19, marking an increase of 5.29.
- For PBT Margin (%), as of Mar 25, the value is 70.08. This value is within the healthy range. It has increased from 65.20 (Mar 24) to 70.08, marking an increase of 4.88.
- For Net Profit Margin (%), as of Mar 25, the value is 65.15. This value exceeds the healthy maximum of 10. It has increased from 58.96 (Mar 24) to 65.15, marking an increase of 6.19.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 140.01. This value exceeds the healthy maximum of 20. It has decreased from 170.56 (Mar 24) to 140.01, marking a decrease of 30.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.28. This value is below the healthy minimum of 15. It has increased from 12.29 (Mar 24) to 13.28, marking an increase of 0.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.60. This value is below the healthy minimum of 10. It has increased from 4.63 (Mar 24) to 6.60, marking an increase of 1.97.
- For Return On Assets (%), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from 11.53 (Mar 24) to 12.41, marking an increase of 0.88.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has increased from 0.06 (Mar 24) to 0.09, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.85, marking an increase of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.49 (Mar 24) to 0.95, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 4. It has decreased from 0.09 (Mar 24) to 0.08, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.83. This value is below the healthy minimum of 20. It has decreased from 21.03 (Mar 24) to 19.83, marking a decrease of 1.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.18. This value is below the healthy minimum of 20. It has decreased from 20.43 (Mar 24) to 19.18, marking a decrease of 1.25.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.17. This value exceeds the healthy maximum of 70. It has increased from 78.97 (Mar 24) to 80.17, marking an increase of 1.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.82. This value exceeds the healthy maximum of 70. It has increased from 79.57 (Mar 24) to 80.82, marking an increase of 1.25.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 68.23. This value is within the healthy range. It has decreased from 100.70 (Mar 24) to 68.23, marking a decrease of 32.47.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 59.51. This value is within the healthy range. It has decreased from 84.77 (Mar 24) to 59.51, marking a decrease of 25.26.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,539.12. It has increased from 2,154.92 (Mar 24) to 2,539.12, marking an increase of 384.20.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.44. This value exceeds the healthy maximum of 3. It has decreased from 13.68 (Mar 24) to 11.44, marking a decrease of 2.24.
- For EV / EBITDA (X), as of Mar 25, the value is 15.06. This value exceeds the healthy maximum of 15. It has decreased from 19.30 (Mar 24) to 15.06, marking a decrease of 4.24.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.40. This value exceeds the healthy maximum of 3. It has decreased from 13.64 (Mar 24) to 11.40, marking a decrease of 2.24.
- For Retention Ratios (%), as of Mar 25, the value is 80.16. This value exceeds the healthy maximum of 70. It has increased from 78.96 (Mar 24) to 80.16, marking an increase of 1.20.
- For Price / BV (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.08, marking an increase of 0.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.40. This value exceeds the healthy maximum of 3. It has decreased from 13.64 (Mar 24) to 11.40, marking a decrease of 2.24.
- For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alembic Ltd:
- Net Profit Margin: 65.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.6% (Industry Average ROCE: 12.59%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.28% (Industry Average ROE: 12.06%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 59.51
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.27 (Industry average Stock P/E: 64.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 65.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | Alembic Road, Vadodra Gujarat 390003 | alembic.investors@alembic.co.in http://www.alembiclimited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chirayu Amin | Chairman |
| Mrs. Malika Amin | Managing Director & CEO |
| Mrs. Rati Desai | Independent Director |
| Mr. Mayurdhvaj Jadeja | Independent Director |
| Mr. Sanjeev Shah | Independent Director |
| Dr. Girish Hirode | Independent Director |
| Mr. Udit Amin | Director |
| Mr. Jain Parkash | Director |
FAQ
What is the intrinsic value of Alembic Ltd?
Alembic Ltd's intrinsic value (as of 03 November 2025) is 84.51 which is 17.15% lower the current market price of 102.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,618 Cr. market cap, FY2025-2026 high/low of 153/85.5, reserves of ₹2,287 Cr, and liabilities of 2,503 Cr.
What is the Market Cap of Alembic Ltd?
The Market Cap of Alembic Ltd is 2,618 Cr..
What is the current Stock Price of Alembic Ltd as on 03 November 2025?
The current stock price of Alembic Ltd as on 03 November 2025 is 102.
What is the High / Low of Alembic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alembic Ltd stocks is 153/85.5.
What is the Stock P/E of Alembic Ltd?
The Stock P/E of Alembic Ltd is 8.27.
What is the Book Value of Alembic Ltd?
The Book Value of Alembic Ltd is 91.1.
What is the Dividend Yield of Alembic Ltd?
The Dividend Yield of Alembic Ltd is 2.35 %.
What is the ROCE of Alembic Ltd?
The ROCE of Alembic Ltd is 6.90 %.
What is the ROE of Alembic Ltd?
The ROE of Alembic Ltd is 13.7 %.
What is the Face Value of Alembic Ltd?
The Face Value of Alembic Ltd is 2.00.